Kintara Therapeutics reminds shareholders to vote by Thursday to facilitate completion of proposed merger with TuHURA Biosciences Page 1

• Shareholders must vote by 11:59 p.m. ET To 19 September 2024 so that your voice counts
• A vote “FOR” on Proposals 3 and 5 by the holders of a majority of the voting rights of Kintara’s outstanding shares at 14 August 2024 is required to complete the planned merger with TuHURA Biosciences

SAN DIEGO, 18 September 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara”), a biopharmaceutical company focused on developing new therapies for solid tumors, reminds shareholders to vote at the upcoming special meeting of shareholders on 20 September 2024 to facilitate the completion of the proposed merger (the “Merger”) with TuHURA Biosciences, Inc. (“TuHURA”).

Kintara urges shareholders to vote by 11:59 p.m. ET on Thursday, September 19, 2024to obtain shareholder approval of the proposals and to enable the completion of the planned merger.